![ajovy copay card ajovy copay card](https://assets.takeda.com/content/dam/takeda/imported/dexilant/images/clinical-results-graph.png)
If you are having difficulty paying for your medicine, AbbVie may be able to help. You are encouraged to report negative side effects of prescription drugs to the FDA. QULIPTA (atogepant) is a prescription medicine used for the preventive treatment of episodic migraine in adults. These are not all the possible side effects of QULIPTA. The most common side effects of QULIPTA are nausea, constipation, and fatigue. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Talk to your healthcare provider about the best way to feed your baby while taking QULIPTA It is not known if QULIPTA passes into your breast milk.
![ajovy copay card ajovy copay card](https://ccopharma.com/wp-content/uploads/2019/11/Bydureon-BCise-300x300.jpg)
It is not known if QULIPTA will harm your unborn baby Are pregnant or plan to become pregnant.
![ajovy copay card ajovy copay card](https://ccopharma.com/wp-content/uploads/2019/11/Daytrana-packages.png)
![ajovy copay card ajovy copay card](https://ccopharma.com/wp-content/uploads/2018/10/2.png)
Have kidney problems or are on dialysis.To learn about AbbVie’s privacy practices and your privacy choices, visit To Pharmacists: For further information, please contact 80.īefore taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you: By redeeming this card, you acknowledge that you are an eligible patient and that you understand and agree to comply with the terms and conditions of this offer. This assistance offer is not health insurance. Restrictions, including duration of the QULIPTA™ (atogepant) Copay Assistance program, available form(s) of copay assistance, and monthly maximums, may apply. Offer to enroll in the QULIPTA™ (atogepant) Copay Assistance Program is subject to change, reduction in amount of monetary assistance, or discontinuance without notice. Patients may not seek reimbursement for value received from QULIPTA Complete from any third-party payers. Patients residing in or receiving treatment in certain states may not be eligible. This payment may not be applied towards any out-of-pocket limits or other deductibles under patient’s insurance coverage. Under this program, once an insurer has established a review process for coverage requests, eligible patients may receive up to a maximum of two 30-day fills at no charge for an FDA approved indication while coverage is pending. Patients may be eligible to receive up to twelve 30-day fills at no charge where coverage is not available until the insurer has established a coverage review process. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, the patient will no longer be able to use the QULIPTA Complete Savings Card, and the patient must call 1.855.QULIPTA to stop participation. The program is not available to cash-paying patients or patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare, Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. The eligibility criteria varies by the form of copay assistance provided and will be made available to you as part of the enrollment process for the form or forms that you apply to receive. Eligibility: Available to patients with commercial prescription insurance coverage for QULIPTA who meet eligibility criteria. Eligible patients will receive copay assistance through one or more forms, such as a savings or copay card, and enrollment requirements may vary. This benefit covers QULIPTA™ (atogepant).